← Leaderboards
Jada Gabrielle Hamilton
Sloan-Kettering Inst Can Research
$5,806,920
Attributed
$7,535,019
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,535,019 · 3
By mechanism
U01$3,664,749 · 1
R01$3,456,199 · 1
R21$414,071 · 1
Top collaborators
- Kenneth Offit4 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Craig B Thompson$56,520,903
- Patricia A Parker$1,910,078
- Xiang Zhang$12,735,442
- Carlos Carmona-Fontaine$3,396,170
Others in their field
Other Emerging Leaders on “Cancer Risk”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$78,058,117
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Dale Sandler · Social And Scientific Systems, Inc.$41,380,317
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,188,684
- Kristin Aillon · Midwest Research Institute$24,228,962
Research focus
Cancer RiskDecision MakingStandard Of CareGenetic CounselingProspectiveBehavioral OutcomeResponseGeneticRandomizedFamilyPathogenicityCommunicationGenetic TestingUptakeResearch DesignMemorial Sloan-Kettering Cancer CenterGenomic MedicineEducationDisclosureEvaluationEducational MaterialsNon-GeneticExperimental StudyVariant
Grant awards (12)
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$844,405
R01 · FY2025 · HG
The IMproving Access to Genetic INformation for Everyone (IMAGINE) Study: A Prospective Trial of a Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Cancer Patients$124,986
U01 · FY2025 · CA · contact PI
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$850,116
R01 · FY2024 · HG
The IMproving Access to Genetic INformation for Everyone (IMAGINE) Study: A Prospective Trial of a Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Cancer Patients$738,070
U01 · FY2024 · CA · contact PI
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$876,679
R01 · FY2023 · HG
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients$744,686
U01 · FY2023 · CA · contact PI
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$884,999
R01 · FY2022 · HG
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients$526,425
U01 · FY2022 · CA · contact PI
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients$733,228
U01 · FY2021 · CA · contact PI
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients$797,354
U01 · FY2020 · CA · contact PI
Responses to Genetic Risk Modifier Testing Among Women with BRCA1/2 Mutations$227,347
R21 · FY2019 · CA · contact PI
Responses to Genetic Risk Modifier Testing Among Women with BRCA1/2 Mutations$186,724
R21 · FY2018 · CA · contact PI